CLINICAL_TRIALS
trial_result
· 2014-10-21
Clinical Trial Update: Effects of Memantine on Magnetic Resonance (MR) Spectroscopy in Subjects at Risk for Alzheimer's Disease [Phase 4]
Summary
Phase 4 clinical trial update examining memantine's effects on MR spectroscopy in subjects at risk for Alzheimer's disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NYU Langone Health | Conditions: Alzheimer's Disease | Phase 4 | Status: COMPLETED | Results posted: 2014-10-21